Home » Stocks » APEN

Apollo Endosurgery, Inc. (APEN)

Stock Price: $5.95 USD 0.39 (7.01%)
Updated Mar 5, 2021 4:00 PM EST - Market closed
Market Cap 154.60M
Revenue (ttm) 42.05M
Net Income (ttm) -22.61M
Shares Out 22.76M
EPS (ttm) -0.99
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day March 5
Last Price $5.95
Previous Close $5.56
Change ($) 0.39
Change (%) 7.01%
Day's Open 5.50
Day's Range 5.04 - 6.07
Day's Volume 270,729
52-Week Range 1.24 - 7.96

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Accesswire - 4 days ago

AUSTIN, TX / ACCESSWIRE / March 3, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, tod...

Accesswire - 6 days ago

AUSTIN, TX / ACCESSWIRE / March 1, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures...

Benzinga - 1 week ago

Apollo Endosurgery (NASDAQ:APEN) announces its next round of earnings this Thursday, February 25. Here is Benzinga's everything-that-matters guide for this Thursday's Q4 earnings announcement.

Accesswire - 2 months ago

AUSTIN, TX / ACCESSWIRE / January 5, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures to...

PRNewsWire - 6 months ago

NEW YORK, Sept. 1, 2020 /PRNewswire/ -- URGENT: SHAREHOLDER VOTE OCTOBER 7, 2020 WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of d...

Seeking Alpha - 10 months ago

Apollo Endosurgery, Inc. (APEN) CEO Todd Newton on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 10 months ago

Top Ranked Momentum Stocks to Buy for April 14th

Other stocks mentioned: AQST, FATE, MRSN
Zacks Investment Research - 1 year ago

The annual U.S. inflation for the month of November beat expectations and put these ETFs and stocks in focus.

Other stocks mentioned: IHF, IHI, IYR, IYT, XLP, BYND, RPT, THC
Seeking Alpha - 1 year ago

Apollo Endosurgery, Inc. (APEN) CEO Todd Newton on Q3 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Apollo Endosurgery, Inc. (APEN) CEO Todd Newton on Q2 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Apollo Endosurgery, Inc. (APEN) CEO Todd Newton on Q1 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Apollo Endosurgery (APEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Seeking Alpha - 1 year ago

Apollo Endosurgery, Inc. (APEN) CEO Todd Newton on Q4 2018 Results - Earnings Call Transcript

About APEN

Apollo Endosurgery, a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to place full thickness sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying... [Read more...]

Industry
Medical Devices
Founded
2005
CEO
Gary Atkinson
Country
United States
Stock Exchange
NASDAQ
Ticker Symbol
APEN
Full Company Profile

Financial Performance

In 2020, APEN's revenue was $42.05 million, a decrease of -17.09% compared to the previous year's $50.71 million. Losses were -$22.61 million, -17.57% less than in 2019.

Financial Statements

Analyst Forecasts

According to 2 analysts, the average rating for APEN stock is "Buy." The 12-month stock price forecast is 8.00, which is an increase of 34.45% from the latest price.

Price Target
$8.00
(34.45% upside)
Analyst Consensus: Buy